AI Portfolio Summary
In 2025 Q4, Vitruvian Partners LLP maintained a portfolio of 7 distinct positions. They heavily accumulated shares in GLOBAL-E, increasing their position by 21.9%. The fund also reduced its exposure to XOMETRY INC by 18.6%.
Total Positions
7
Quarter
2025 Q4
Top Holding
HNGE (41.7%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-7 of 7
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HNGE
HINGE HEALTH IN...
|
Healthcare | 41.73% | 42.55% |
#1
Prev: #1
|
10.0 | no change | no change |
P
S
|
1,250,000 | $58,062,500 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MQ
MARQETA
|
Technology | 23.39% | 25.10% |
#2
Prev: #2
|
9.4 | no change | no change |
P
S
|
6,853,183 | $32,552,619 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CARG
CARGURUS INC
|
Consumer Cyclical | 13.03% | 12.21% |
#3
Prev: #3
|
5.2 | no change | no change |
P
S
|
472,959 | $18,137,978 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XMTR
XOMETRY INC
|
Industrials | 8.20% | 8.90% |
#4
Prev: #4
|
3.3 | -43,741 | -18.6% |
P
S
|
191,919 | $11,413,423 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GLBE
GLOBAL-E
|
Consumer Cyclical | 5.94% | 4.28% |
#5
1
Prev: #6
|
4.4 | 37,767 | 21.9% |
P
S
|
210,209 | $8,263,316 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MXCT
MAXCYTE
|
Healthcare | 5.62% | 5.53% |
#6
1
Prev: #5
|
2.2 | no change | no change |
P
S
|
5,043,356 | $7,817,202 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RXST
RXSIGHT
|
Healthcare | 2.09% | 1.44% |
#7
Prev: #7
|
2.9 | 48,122 | 20.9% |
P
S
|
278,865 | $2,905,773 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-7 of 7 holdings